1919 Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

1919 Investment Counsel’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$344K	Buy	3,515 +31	+0.9%	+$3.05K	0.01%	486
2014 Q2	$352K	Hold	3,484	–	–	0.01%	477
2014 Q1	$320K	Sell	3,484 -691	-17%	-$63.7K	0.01%	483
2013 Q4	$378K	Sell	4,175 -444	-10%	-$38.4K	0.01%	464
2013 Q3	$369K	Buy	4,619 +52	+1%	+$4.09K	0.01%	455
2013 Q2	$333K	Buy	+4,567	New	+$341K	0.01%	447

Other funds holding ZBH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

1919 Investment Counsel's ZBH Position: Q3 2014 in Review

1919 Investment Counsel increased its Zimmer Biomet (ZBH) stake by 0.89% in Q3 2014, buying an estimated $3.05K and bringing the position to 3,515 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #486.

1919 Investment Counsel first reported a position in ZBH in Q2 2013 and has held it in 6 quarters since. The position peaked at $378K in Q4 2013. 721 funds tracked by Wall St. Rank hold ZBH as of Q3 2014.

1919 Investment Counsel held 3,515 shares of Zimmer Biomet worth $344K as of Q3 2014.
1919 Investment Counsel bought 31 Zimmer Biomet shares in Q3 2014, an estimated $3.05K.
Zimmer Biomet made up 0.01% of 1919 Investment Counsel's portfolio in Q3 2014, its #486 holding.
1919 Investment Counsel first reported a position in Zimmer Biomet in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Zimmer Biomet position peaked at $378K in Q4 2013.
721 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.